126 
1 AFTERNOON SESSION 
2 1:15 p.ra. 
3 MR. LIBASSI: I think we can begin. I just 
4 wanted to make a few comments and observations if I 
5 could, very briefly, while we are gathering. One is 
6 that I wanted to remind everyone that September 26 
7 was the closing date for receipt of comments with respect 
8 to the proposed revised guidelines, so that if anyone 
9 wishes to — who has not made a statement or submitted 
10 a statement — wishes to do so, please do so by that 
11 date. If anyone wants to amplify on what they have 
12 already submitted, they may do that, and we would be 
13 glad to get additional comments from anyone, as long 
14 as they are in by the 26 th. 
15 I did want to recognize Dr. Jane Setlow, who 
16 is the Chairman of the NIH Recombinant DNA Advisory 
17 Committee, and not only recognize you, Jane, but also 
18 the work of the committee and our appreciation for the 
19 extensive efforts that you already have put into this, 
20 and the hearings that you all have held, and the time 
21 and effort that you have contributed. It is appreciated 
22 as part of the way the policy ultimately is made. I 
23 want to thank you at this point publicly. 
24 The only other observation I wanted to make 
25 was the appreciation for the statements that have been 
[ 218 ] 
